Article Details
Retrieved on: 2017-12-19 21:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Russell Investments Group Ltd. now owns 35,588 shares of the biopharmaceutical company's stock valued at $4,331,000 after acquiring an additional 6,438 shares during the period. <b>Acadian Asset Management</b> LLC bought a new stake in shares of Alexion Pharmaceuticals in the second quarter valued ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here